Remy
Administrator
Merck itself says that it is ineffective at the dose approved by the FDA. Yet they're still selling it and it's on track to be a best-seller.
Don't be tempted because studies show it just plain doesn't work.
Full text here.
Don't be tempted because studies show it just plain doesn't work.
People taking Belsomra fell asleep, on average, only six minutes sooner than people taking a placebo and stayed asleep for a mere 16 minutes longer. Some test subjects experienced worrying side effects, like next-day drowsiness and temporary paralysis upon waking. For a number of people, these effects were so severe that the researchers halted their driving tests, fearing someone would get into an accident. Because of these safety concerns, the FDA ended up approving the drug at a lower starting dosage than the company had requested—a dosage so low that a Merck scientist admitted it was “ineffective.”
Full text here.